And then, Walle et al. found that NASH was associated with higher mRNA expression levels of FADS1, FADS2, and stearoyl-CoA desaturase (SCD) genes in the liver [17]. This evidence concerns the gene FADS1 and metabolic dysfunction-associated steatohepatitis.